Cardiol Therapeutics Inc.
CRDL Nasdaq
SEC CIK 1702123
Follow Cardiol Therapeutics
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −CAD 33.8M |
| FY24 | −CAD 36.7M |
| FY23 | −CAD 28.1M |
| FY22 | −CAD 30.9M |
| FY21 | −CAD 31.6M |
| FY20 | −CAD 20.6M |
| FY19 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −CAD 23.9M |
| FY24 | −CAD 25.1M |
| FY23 | −CAD 25.2M |
| FY22 | −CAD 27.3M |
| FY21 | −CAD 23.6M |
| FY20 | −CAD 9.2M |
| FY19 | - |